- Topics
- Webcasts & Training
- Events
This timely event will cover the regulatory shift in the U.S. on ESG-centered disclosure; calls for a global, standardized reporting framework; preventing greenwashing in one’s marketing and public relations efforts; third-party risk management; and technology solutions in ESG reporting, monitoring, and benchmarking contexts.
Register
- Resource Library
- Special Reports
- Video
- Membership
Learn from the latest headlines and protect your company today
- Amazon discloses record-shattering $887M GDPR fine
- Seven things whistleblowers want compliance officers to know
- KPMG fined $18M for ‘integrity and objectivity’ breaches in Silentnight sale
- Acting FinCEN head to step down; new search underway
Individual Corporate
Close menu
- Home
-
Topics
- Back to parent navigation item
- Topics
- Accounting & Auditing
- AML
- Anti-Bribery
- Anti-Corruption
- Boards & Shareholders
- Cyber-Security
- Data Privacy
- ESG/Social Responsibility
- Ethics & Culture
- Europe
- Financial Services
- GRC Appointments
- Internal Controls
- Regulatory Enforcement
- Regulatory Policy
- Risk Management
- Sanctions
- Surveys & Benchmarking
- Supply Chain
- Technology
- Third Party Risk
- Whistleblowers
- Compensation
- GDPR
- Internal Investigations
- Opinion
- Training
- Culture
- GRC Announcements
- My Compliance Library
- Ask Amii Mailbag
- Nailed It or Failed It
- Risk and Regulatory Compliance
- Accounting and Audit
- Webcasts & Training
- Events
- Resource Library
- Special Reports
- Video
- Membership
Sanofi: Department of Justice ends FCPA probe
By Jaclyn Jaeger2018-03-09T11:45:00
French pharmaceutical company Sanofi said that the U.S. Department of Justice has closed its inquiry into allegations concerning potential violations of the U.S. Foreign Corrupt Practices Act.
WELCOME TO OUR OPEN HOUSE – LOG IN TO CONTINUE READING FOR FREE
If you are already a registered user or a member, SIGN IN now.